120 results
8-K
EX-99.1
wp2 17wnxf
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.2
uapz0f ak3zx9qt4p5f
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.1
xjnwjxg10x0r 1fw
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-2.1
m7j6mtz
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
d17hr12 qgt
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
htaii2ui eagdf
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
q5zob5ld7x772crqb
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
l8t0 btz3z0w
12 Sep 23
Prospectus supplement for primary offering
6:04am
424B3
yhg2k3 tjm
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
49hqhtux
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm